Current evidence of a deintensification strategy for patients with HPV-related oropharyngeal cancer

SY Sung, YS Kim, SH Kim, SJ Lee, SW Lee, YK Kwak - Cancers, 2022 - mdpi.com
Simple Summary Human papillomavirus (HPV)-related oropharyngeal cancer represents a
distinct disease entity, showing favorable treatment responses and survival outcomes. While …

The dual role of autophagy in HPV-positive head and neck squamous cell carcinoma: a systematic review

SA Kandathil, A Akhondi, L Kadletz-Wanke… - Journal of Cancer …, 2024 - Springer
Purpose Human papilloma virus (HPV)-positive head and neck squamous cell carcinoma
(HNSCC) displays distinct epidemiological, clinical, and molecular characteristics compared …

Comparison of selected immune and hematological parameters and their impact on survival in patients with HPV-related and HPV-unrelated oropharyngeal Cancer

A Brewczyński, B Jabłońska, AM Mazurek… - Cancers, 2021 - mdpi.com
Simple Summary This is a research article on oropharyngeal cancer (OPC). The aim of the
study was to assess and compare basic immune parameters and ratios in patients with …

[HTML][HTML] NF-κB over-activation portends improved outcomes in HPV-associated head and neck cancer

TP Schrank, AC Prince, T Sathe, X Wang, X Liu… - Oncotarget, 2022 - ncbi.nlm.nih.gov
Evolving understanding of head and neck squamous cell carcinoma (HNSCC) is leading to
more specific diagnostic disease classifications. Among HNSCC caused by the human …

[HTML][HTML] Challenges and Considerations in Diagnosing and Managing p16+-Related Oropharyngeal Squamous Cell Carcinoma (OPSCC) with Neck Metastasis …

G Motta, B Brandolini, T Di Meglio, S Allosso… - Journal of Clinical …, 2024 - mdpi.com
Background: The incidence of patients showing neck metastasis and no obvious primary
tumor at the initial diagnostic evaluation or neck cancer of unknown primary (NCUP) is …

Concurrent cetuximab-based bioradiotherapy versus cisplatin-based chemoradiotherapy in the definitive management of favourable biology human papillomavirus …

M Swain, S Kannan, S Srinivasan, JP Agarwal, T Gupta - Clinical Oncology, 2022 - Elsevier
Replacing cisplatin with cetuximab concurrently during radiotherapy has been one of the
strategies of treatment de-escalation in human papillomavirus (HPV)-associated …

HPV-Related Cancers in Bosnia and Herzegovina: A Comprehensive Review

A Paric, K Tomic, L Alidzanovic, A Fojnica… - Acta Medica …, 2024 - ama.ba
This review assesses the burden of human papillomavirus (HPV)-related cancers in Bosnia
and Herzegovina (BH), aiming to inform strategies for prevention and early detection …

HPV 阳性口咽癌降低强度治疗研究进展

杜有芹, 莫柒艳, 曲颂 - 中国癌症防治杂志, 2022 - zgazfz.com
近年来, 人乳头瘤病毒(human papillomavirus, HPV) 阳性口咽癌的发病率不断上升.
目前认为其是一种与HPV 阴性口咽癌完全不同的疾病, 具有独特的临床及生物学特性 …

[HTML][HTML] DNA damage response and potential biomarkers of radiosensitivity in head and neck cancers: clinical implications

D Carpov, R Buigă, VM Nagy - Romanian Journal of Morphology …, 2023 - ncbi.nlm.nih.gov
Head and neck cancers include a wide variety of tumor sites that originate in the epithelium
of the upper aerodigestive airways. The curative treatment of this group of pathologies most …

[PDF][PDF] Comparison of Selected Immune and Hematological Parameters and Their Impact on Survival in Patients with HPV-Related and HPV-Unrelated Oropharyngeal …

AM Mazurek, J Mrochem-Kwarciak, S Mrowiec… - 2021 - academia.edu
Several immune and hematological parameters are associated with survival in patients with
oropharyngeal cancer (OPC). The aim of the study was to analyze selected immune and …